Incadronate disodium inhibits advanced glycation end products-induced angiogenesis in vitro. 2002

Tamami Okamoto, and Sho-ichi Yamagishi, and Yosuke Inagaki, and Shinjiro Amano, and Masayoshi Takeuchi, and Seiji Kikuchi, and Shigeaki Ohno, and Akihiko Yoshimura
Division of Endocrinology and Metabolism, Department of Medicine, Kurume University School of Medicine, Japan.

We have previously shown that advanced glycation end products (AGE), senescent macroprotein derivatives formed at an accelerated rate in diabetes, induced angiogenesis through overgeneration of autocrine vascular endothelial growth factor (VEGF). In the present study, effects of incadronate disodium, a nitrogen-containing bisphosphonate on AGE-elicited angiogenesis in vitro, were studied. Incadronate disodium was found to completely inhibit AGE-induced increase in DNA synthesis as well as tube formation of human microvascular endothelial cells (EC). Furthermore, incadronate disodium significantly prevented transcriptional activation of nuclear factor-kappaB and activator protein-1 and the subsequent up-regulation of VEGF mRNA levels in AGE-exposed EC. Farnesyl pyrophosphate, but not geranylgeranyl pyrophosphate, was found to completely restore the anti-angiogenic effects of incadronate disodium on EC. These results suggest that incadronate disodium could block the AGE-signaling pathway in microvascular EC through inhibition of protein farnesylation. Incadronate disodium may be a promising remedy for treatment of patients with proliferative diabetic retinopathy.

UI MeSH Term Description Entries
D008222 Lymphokines Soluble protein factors generated by activated lymphocytes that affect other cells, primarily those involved in cellular immunity. Lymphocyte Mediators,Mediators, Lymphocyte
D009389 Neovascularization, Pathologic A pathologic process consisting of the proliferation of blood vessels in abnormal tissues or in abnormal positions. Angiogenesis, Pathologic,Angiogenesis, Pathological,Neovascularization, Pathological,Pathologic Angiogenesis,Pathologic Neovascularization,Pathological Angiogenesis,Pathological Neovascularization
D011106 Polyisoprenyl Phosphates Phosphoric or pyrophosphoric acid esters of polyisoprenoids. Isoprenoid Phosphates,Terpene Phosphates,Phosphates, Isoprenoid,Phosphates, Polyisoprenyl,Phosphates, Terpene
D011401 Promoter Regions, Genetic DNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes. rRNA Promoter,Early Promoters, Genetic,Late Promoters, Genetic,Middle Promoters, Genetic,Promoter Regions,Promoter, Genetic,Promotor Regions,Promotor, Genetic,Pseudopromoter, Genetic,Early Promoter, Genetic,Genetic Late Promoter,Genetic Middle Promoters,Genetic Promoter,Genetic Promoter Region,Genetic Promoter Regions,Genetic Promoters,Genetic Promotor,Genetic Promotors,Genetic Pseudopromoter,Genetic Pseudopromoters,Late Promoter, Genetic,Middle Promoter, Genetic,Promoter Region,Promoter Region, Genetic,Promoter, Genetic Early,Promoter, rRNA,Promoters, Genetic,Promoters, Genetic Middle,Promoters, rRNA,Promotor Region,Promotors, Genetic,Pseudopromoters, Genetic,Region, Genetic Promoter,Region, Promoter,Region, Promotor,Regions, Genetic Promoter,Regions, Promoter,Regions, Promotor,rRNA Promoters
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004164 Diphosphonates Organic compounds which contain P-C-P bonds, where P stands for phosphonates or phosphonic acids. These compounds affect calcium metabolism. They inhibit ectopic calcification and slow down bone resorption and bone turnover. Technetium complexes of diphosphonates have been used successfully as bone scanning agents. Bisphosphonate,Bisphosphonates
D004730 Endothelium, Vascular Single pavement layer of cells which line the luminal surface of the entire vascular system and regulate the transport of macromolecules and blood components. Capillary Endothelium,Vascular Endothelium,Capillary Endotheliums,Endothelium, Capillary,Endotheliums, Capillary,Endotheliums, Vascular,Vascular Endotheliums
D005419 Flavonoids A group of phenyl benzopyrans named for having structures like FLAVONES. 2-Phenyl-Benzopyran,2-Phenyl-Chromene,Bioflavonoid,Bioflavonoids,Flavonoid,2-Phenyl-Benzopyrans,2-Phenyl-Chromenes,2 Phenyl Benzopyran,2 Phenyl Benzopyrans,2 Phenyl Chromene,2 Phenyl Chromenes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Tamami Okamoto, and Sho-ichi Yamagishi, and Yosuke Inagaki, and Shinjiro Amano, and Masayoshi Takeuchi, and Seiji Kikuchi, and Shigeaki Ohno, and Akihiko Yoshimura
March 2002, Microvascular research,
Tamami Okamoto, and Sho-ichi Yamagishi, and Yosuke Inagaki, and Shinjiro Amano, and Masayoshi Takeuchi, and Seiji Kikuchi, and Shigeaki Ohno, and Akihiko Yoshimura
January 2018, Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology,
Tamami Okamoto, and Sho-ichi Yamagishi, and Yosuke Inagaki, and Shinjiro Amano, and Masayoshi Takeuchi, and Seiji Kikuchi, and Shigeaki Ohno, and Akihiko Yoshimura
January 2011, Experimental biology and medicine (Maywood, N.J.),
Tamami Okamoto, and Sho-ichi Yamagishi, and Yosuke Inagaki, and Shinjiro Amano, and Masayoshi Takeuchi, and Seiji Kikuchi, and Shigeaki Ohno, and Akihiko Yoshimura
September 2014, Nutrition research (New York, N.Y.),
Tamami Okamoto, and Sho-ichi Yamagishi, and Yosuke Inagaki, and Shinjiro Amano, and Masayoshi Takeuchi, and Seiji Kikuchi, and Shigeaki Ohno, and Akihiko Yoshimura
October 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
Tamami Okamoto, and Sho-ichi Yamagishi, and Yosuke Inagaki, and Shinjiro Amano, and Masayoshi Takeuchi, and Seiji Kikuchi, and Shigeaki Ohno, and Akihiko Yoshimura
January 2008, Microvascular research,
Tamami Okamoto, and Sho-ichi Yamagishi, and Yosuke Inagaki, and Shinjiro Amano, and Masayoshi Takeuchi, and Seiji Kikuchi, and Shigeaki Ohno, and Akihiko Yoshimura
January 2011, Contributions to nephrology,
Tamami Okamoto, and Sho-ichi Yamagishi, and Yosuke Inagaki, and Shinjiro Amano, and Masayoshi Takeuchi, and Seiji Kikuchi, and Shigeaki Ohno, and Akihiko Yoshimura
October 2002, Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie,
Tamami Okamoto, and Sho-ichi Yamagishi, and Yosuke Inagaki, and Shinjiro Amano, and Masayoshi Takeuchi, and Seiji Kikuchi, and Shigeaki Ohno, and Akihiko Yoshimura
April 2003, The American journal of pathology,
Tamami Okamoto, and Sho-ichi Yamagishi, and Yosuke Inagaki, and Shinjiro Amano, and Masayoshi Takeuchi, and Seiji Kikuchi, and Shigeaki Ohno, and Akihiko Yoshimura
August 2023, Current medical science,
Copied contents to your clipboard!